OPTI-AML: PROSPECTIVE RANDOMIZED PHASE 2 TRIAL OF 28 VERSUS 14 DAY SCHEDULE OF VENETOCLAX AND AZACITIDINE FOR 2 CYCLES IN NEWLY DIAGNOSED GENOMICALLY AGNOSTIC ACUTE MYELOID LEUKEMIA PATIENTS ≥60 YEARS

EHA Library, Uma Borate, 4206680

A MULTICENTER PHASE 1B/2 TRIAL OF AZACITIDINE, VENETOCLAX, AND IVOSIDENIB IN IDH1-MUTATED ACUTE MYELOID LEUKEMIA (AML)

EHA Library, Jennifer Marvin-Peek, 4206681

VENETOCLAX AND AZACITIDINE FOR MOLECULAR FAILURE INTERVENTION AS A BRIDGE-TO-TRANSPLANT STRATEGY FOR NPM1-MUTATED ACUTE MYELOID LEUKEMIA: THE GIMEMA AML2521 PHASE 2 TRIAL

EHA Library, Chiara Sartor, 4206682

PROSPECTIVE NAMLG LD-VENEX TRIAL: AZACITIDINE IN COMBINATION WITH REDUCED DURATION OF VENETOCLAX IN PATIENTS WITH DE NOVO, SECONDARY, AND RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA

EHA Library, Anne Louise Tølbøll Sørensen, 4206683

BCR-REGULATED LNCRNA LINC00173 LIMITS RIBONUCLEOPROTEIN GRANULES (RNP) ASSEMBLY TO CONTROL MRNA TRANSLATION IN CLL

EHA Library, Pedro Faria Zeni, 4206695

RESOLVING THE TUMOR HETEROGENEITY OF CLL SUBSET #8 AT SINGLE-CELL RESOLUTION: INSIGHTS INTO CLONAL DYNAMICS AND DISTINCT SUB-CLONAL MUTATIONAL LANDSCAPES

EHA Library, Athanasios Roussos, 4206696

ASC4FIRST WK 144 ANALYSIS: CONTINUED SUPERIOR EFFICACY AND FAVORABLE SAFETY OF ASCIMINIB VS INVESTIGATOR-SELECTED TYROSINE KINASE INHIBITORS IN NEWLY DIAGNOSED CHRONIC PHASE CHRONIC MYELOID LEUKEMIA

EHA Library, Timothy Hughes, 4206714

HIGH RATES OF SUCCESSFUL SECOND STOP ATTEMPTS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA: RESULTS OF THE NAUT TRIAL

EHA Library, Katharina Kohlbrenner, 4206716

EFFICACY AND SAFETY OF ADDING LOW DOSE TYROSINE KINASE INHIBITORS (TKIS) FOR PATIENTS WITH CHRONIC MYELOID LEUKEMIA WHO DO NOT ACHIEVE OPTIMAL RESPONSE OR A DEEP MOLECULAR REMISSION (ALERT CML)

EHA Library, Jay Yang, 4206717

ENABLE: UPDATED EFFICACY AND SAFETY RESULTS OF ELVN-001, A NOVEL SELECTIVE ATP-COMPETITIVE INHIBITOR OF BCR::ABL1, IN PATIENTS WITH PREVIOUSLY TREATED CP-CML

EHA Library, Dennis Kim, 4206718

IN VIVO LENTIVIRAL GENE TRANSFER INTO HEMATOPOIETIC STEM CELLS FOR THE TREATMENT OF FANCONI ANEMIA

EHA Library, Michela Milani, 4206730

LONG-TERM OUTCOMES IN PATIENTS WITH RELAPSED OR REFRACTORY SEVERE APLASTIC ANEMIA

EHA Library, Fieke Hoff, 4206732

REAL-WORLD EXPERIENCE OF MITAPIVAT IN PYRUVATE KINASE DEFICIENCY

EHA Library, Giacinto Luca Pedone, 4206856

PROSPECTIVE VALIDATION OF A WEIGHTED GAH SCORE IN PATIENTS ≥65 YEARS WITH LYMPHOPROLIFERATIVE NEOPLASMS: TOXICITY PREDICTION AND PROGNOSTIC IMPACT

EHA Library, Josefa Marco Buades, 4206894

TREATMENT ACCESS ELIMINATES RACIAL DISPARITIES BUT CANNOT OVERCOME STRUCTURAL POVERTY: A NATIONAL ANALYSIS OF SURVIVAL EQUITY IN CURABLE LYMPHOMA

EHA Library, Shivam Patel, 4206895

EPCORITAMAB + R-MINI-CHOP RESULTS IN 2-YEAR REMISSIONS AND HIGH MRD-NEGATIVITY RATES IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED DLBCL: RESULTS FROM THE EPCORE NHL-2 TRIAL

EHA Library, David Belada, 4206896

DEVELOPMENT AND VALIDATION OF A CLINICOPATHOLOGICAL PROGNOSTIC MODEL FOR PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA

EHA Library, Yupiao Feng, 4206900

EXTRANODAL METABOLIC TUMOR VOLUME IDENTIFIES LARGE B‑CELL LYMPHOMA SUBGROUPS THAT BENEFIT FROM POLA‑R‑CHP

EHA Library, Hajime Sakuma, 4206901

REAL-WORLD (RW) TREATMENT PATTERNS AND SURVIVAL OUTCOMES IN PATIENTS (PTS) WITH NEWLY DIAGNOSED HIGH-RISK (HR) LARGE B-CELL LYMPHOMA (LBCL)

EHA Library, Javier Munoz, 4206903

RECEIPT OF HOLDING THERAPY IS ASSOCIATED WITH INFERIOR OUTCOMES ACROSS THE CAR T TREATMENT PATHWAY IN RELAPSED/REFRACTORY LARGE B CELL LYMPHOMA

EHA Library, Inna Gong, 4206904

THE CLINICAL SIGNIFICANCE OF MYC::BCL6 FUSION IN MYC/BCL6 DOUBLE HIT LYMPHOMA PATIENTS

EHA Library, Shaoying Li, 4206905

POLA-R-CHP VS R-EPOCH FOR FRONTLINE THERAPY IN DLBCL WITH EXTRANODAL INVOLVEMENT

EHA Library, Li Bao, 4206906

IMMUNE DEFICIENCY AND INFECTION RISK FOLLOWING  SECOND LINE CAR-T CELLS THERAPY IN RELAPSED REFRACTORY LARGE B CELLS LYMPHOMA

EHA Library, Mohamad Sabbah, 4206908

FLOW CYTOMETRY OF VITRECTOMY SAMPLES AS A DIAGNOSTIC TOOL IN PRIMARY VITREORETINAL LYMPHOMA

EHA Library, Lena-Marie Poczka, 4206909

INTERNATIONAL EXPERT CONSENSUS ON REAL-WORLD CAR T-CELL ELIGIBILITY IN LARGE B-CELL LYMPHOMAS: AN E-DELPHI STUDY

EHA Library, Catherine Thieblemont, 4206912

LARGE B-CELL LYMPHOMA TREATMENT WITH LONCASTUXIMAB TESIRINE IN AN ITALIAN REAL-LIFE EXPERIENCE

EHA Library, Alessandro Broccoli, 4206913

EARLY TOXICITY OF AXICABTAGENE CILOLEUCEL BY LINE OF THERAPY IN DLBCL: A REAL-WORLD COMPARISON OF 2L VS ≥3L TREATMENT

EHA Library, Rebeca Bailen, 4206915

OVERALL AND PROGRESSION-FREE SURVIVAL IN PATIENTS WITH EPSTEIN-BARR VIRUS-DRIVEN POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE (EBV+ PTLD) TREATED WITH TABELECLEUCEL IN THE PHASE 3 ALLELE TRIAL

EHA Library, Sylvain Choquet, 4206918

PRELIMINARY EFFICACY AND SAFETY OF GOLIDOCITINIB IN RELAPSED/REFRACTORY T CELL AND NK CELL LARGE GRANULAR LYMPHOCYTE LEUKEMIA

EHA Library, Ying Yu, 4206920

FIRST REPORT OF ROCBRUTINIB FOR THE TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA

EHA Library, Yuqin Song, 4206922

THE REAL-WORLD EFFICACY OF BRUTON’S TYROSINE KINASE INHIBITORS PLUS HIGH-DOSE METHOTREXATE BASED INDUTION TREATMENT FOR UNTREATED PRIMARY CNS LYMPHOMA: A SINGLE-CENTER RETROSPECTIVE ANALYSIS.

EHA Library, He Huang, 4206924

CHIDAMIDE IN COMBINATION WITH CHOP IN PREVIOUSLY UNTREATED PERIPHERAL T-CELL LYMPHOMA WITH T FOLLICULAR HELPER PHENOTYPE–RESULTS OF PHASE II SWIFT TRIAL

EHA Library, Qingqing Cai, 4206925

THE AITL-HZ SCORE INCORPORATING EBV AND COMPLEMENT C3 OUTPERFORMS EXISTING PROGNOSTIC MODELS FOR CHINESE AITL PATIENTS

EHA Library, Mengmeng Dong, 4206926

MANAGEMENT AND OUTCOME OF SECONDARY CENTRAL NERVOUS SYSTEM (CNS) INVOLVEMENT IN AN INTERNATIONAL COHORT OF 62 PATIENTS WITH PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL)

EHA Library, Andrés José María Ferreri, 4206929

TABELECLEUCEL FOR ALLOGENEIC OR SOLID ORGAN TRANSPLANT RECIPIENTS WITH EBV+ PTLD AFTER FAILURE OF RITUXIMAB OR RITUXIMAB PLUS CHEMOTHERAPY: PAEDIATRIC SUBGROUP ANALYSIS OF THE PHASE 3 ALLELE STUDY

EHA Library, Pere Barba, 4206930

FINAL RESULTS OF THE PHASE II S-IDE STUDY: ADDING SELINEXOR TO IFOSFAMIDE, ETOPOSIDE, AND DEXAMETHASONE DID NOT IMPROVE OUTCOMES IN RELAPSED/REFRACTORY PERIPHERAL T-CELL LYMPHOMAS

EHA Library, Annalisa Chiappella, 4206932

MOLECULAR LANDSCAPE OF PEDIATRIC B-CELL LYMPHOBLASTIC LYMPHOMA

EHA Library, Ekaterina Romanenko, 4206933

AN OPEN LABEL, PHASE 2 TRIAL EVALUATING DARATUMUMAB-BORTEZOMIB-DEXAMETHASONE COMBINATION IN RELAPSED OR REFRACTORY PLASMABLASTIC LYMPHOMA: THE DALYA TRIAL ON BEHALF OF THE FONDAZIONE ITALIANA LINFOMI

EHA Library, Andrés José María Ferreri, 4206934

FACILITY-LEVEL DIFFERENCES TRANSLATE INTO LIVES LOST: ELDERLY PRIMARY CNS LYMPHOMA IN THE NATIONAL CANCER DATABASE

EHA Library, Rosa Rios, 4206936

FINAL RESULTS OF A PHASE II STUDY OF THE ANTI-PROGRAMMED CELL DEATH LIGAND-1 (PD-L1) ANTIBODY ATEZOLIZUMAB IN RELAPSED/REFRACTORY EXTRANODAL NK/T-CELL LYMPHOMA: THE NCCH1903/ATTACK STUDY

EHA Library, Shinichi Makita, 4206938

BRENTUXIMAB VEDOTIN PLUS CHP-LIKE VERSUS CHOEP REGIMEN FOR THE FIRST-LINE TREATMENT OF PTCL PATIENTS: A MULTI-CENTER PROPENSITY-MATCHED POPULATION-BASED STUDY

EHA Library, Jun Fang, 4206940

INCIDENCE AND PREDICTORS OF CARDIOVASCULAR EVENTS AFTER ANTHRACYCLINE-CONTAINING CHEMOTHERAPY IN LYMPHOMA: A RETROSPECTIVE LONGITUDINAL COHORT

EHA Library, Dewan Zhao, 4206944

SURVIVAL BENEFIT ASSOCIATED WITH TREATMENT AT ACADEMIC CANCER PROGRAMS IN OLDER ADULTS WITH PTCL: A NATIONAL CANCER DATABASE ANALYSIS

EHA Library, Henry Idrobo, 4206945

PHASE IB STUDY OF SHR0302 PLUS SHR2554 IN RELAPSED/REFRACTORY PERIPHERAL T-CELL LYMPHOMA: SAFETY RUN-IN AND INITIAL EFFICACY

EHA Library, Rong Tao, 4206946

CHANGES IN LEAN MUSCLE MASS, MUSCLE STRENGTH, AND PHYSICAL PERFORMANCE FOLLOWING FIRST‐LINE CHEMOTHERAPY IN PATIENTS WITH MALIGNANT LYMPHOMA

EHA Library, Charlotte Grønset, 4206948

MENDELIAN RANDOMIZATION REVEALS THE CAUSATIVE ROLE OF GENETICALLY PREDICTED VIRAL INFECTION IN PAN-LYMPHOMA RISK

EHA Library, Haiwen Huang, 4206949

TOTAL METABOLIC TUMOR VOLUME AND CIRCULATING TUMOR DNA AS EARLY PROGNOSTIC FACTORS IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: RESULTS FROM THE PHASE 3 STARGLO TRIAL

EHA Library, William Townsend, 4206950

EARLY OUTCOME PREDICTION OF DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS USING ON-TREATMENT OMICS DATA

EHA Library, Tom van den Bosch, 4206952

PLASMA PROTEOMIC SIGNATURES DISTINGUISH LYMPHOMA FROM OTHER CANCERS AND NON-MALIGNANT CONDITIONS IN PATIENTS PRESENTING WITH NON-SPECIFIC SYMPTOMS

EHA Library, Fredrika Wannberg, 4206953

PREVALENCE AND UTILITY OF JAK2V617F TESTING IN PATIENTS WITH CRYPTOGENIC STROKE

EHA Library, Maria Alicia Senin Magan, 4213523

UNRAVELING THE ROLE OF KIELIN/CHORDIN-LIKE PROTEIN KCP AS A NOVEL MODULATOR OF HEPCIDIN IN HEPATOCYTES

EHA Library, Laura Silvestri, 4213524

IMMUNOGLOBULIN-ASSOCIATED TRANSFUSION-RELATED ACUTE LUNG INJURY & TRANSFUSION-ASSOCIATED CIRCULATORY OVERLOAD OVERLAP IN REFRACTORY IMMUNE THROMBOCYTOPENIA

EHA Library, Milica Apostolovic Stojanovic, 4213525

EARLIER CILTACABTAGENE AUTOLEUCEL (CILTA-CEL) USE AND BETTER IMMUNE FITNESS (IF) BASED ON CORRELATIVE ANALYSIS OF PERIPHERAL BLOOD AND BONE MARROW TUMOR MICROENVIRONMENT (TME) FROM CARTITUDE-4

EHA Library, SAMIR PAREKH, 4214435

LOW-DOSE CYTARABINE AND VENETOCLAX PLUS AZACITIDINE COMPARED WITH VENETOCLAX PLUS AZACITIDINE IN OLDER PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: A MULTICENTER RANDOMIZED PHASE III TRIAL

EHA Library, Xiao Han, 4206679

TISAGENLECLEUCEL IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH HIGH-RISK B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AND MINIMAL RESIDUAL DISEASE AT THE END OF FRONTLINE CONSOLIDATION

EHA Library, Shannon Maude, 4206689

IMPACT OF TWO VERSUS THREE CHEMOTHERAPY CYCLES BEFORE HSCT IN MRD-NEGATIVE PEDIATRIC AML: A MULTICENTER RETROSPECTIVE STUDY

EHA Library, Lindsey Murphy, 4206690

ANTHRACYCLINES-FREE TREATMENT OF 114 CHILDREN AND ADOLESCENTS WITH NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL): EARLY FINAL RESULTS OF THE ICC-APL-02 STUDY.

EHA Library, Franco Locatelli, 4206691

LUVOMETINIB IN RECURRENT/REFRACTORY PEDIATRIC LANGERHANS CELL HISTIOCYTOSIS: A PHASE 2 TRIAL

EHA Library, Rui Zhang, 4206692

EZH2 INACTIVATION AND HOXA9-MEDIATED REPROGRAMMING DRIVE HUMAN T-CELL LEUKEMOGENESIS AND DEFINE HIGH-RISK EARLY T-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (ETP-ALL)

EHA Library, Vincenzo Giambra, 4206693

CLONAL TRAJECTORIES OF CHRONIC LYMPHOCYTIC LEUKEMIA AND RICHTER TRANSFORMATION OVER THE PATIENTS’ LIFESPAN

EHA Library, Ian Márquez-López, 4206694

PROSPECTIVE VALIDATION OF THE CLL-TIM MACHINE-LEARNING ALGORITHM PREDICTING INFECTION AND TREATMENT IN CLL: RESULTS FROM THE PHASE 2 CLINICAL TRIAL PREVENT-ACALL, NON-RANDOMIZED COHORT

EHA Library, Carsten Niemann, 4206697

A RIBOCANCER CELL LINE PANEL REVEALS THAT CLL-ASSOCIATED RPS15 MUTATIONS TRANSLATIONALLY REWIRE TRANSCRIPTION THROUGH CODON-SPECIFIC TRNA ACCOMMODATION DEFECTS

EHA Library, Marino Caruso, 4206698

PONATINIB CONSOLIDATION AND DISCONTINUATION IN CML PATIENTS AFTER FAILED FIRST TFR ATTEMPT: UPDATED TFR OUTCOMES AND CHIP MUTATION ANALYSIS FROM THE RESTOP TRIAL

EHA Library, Gonzalo Carreño Gómez-Tarragona, 4206715

CLONAL ARCHITECTURE AND DYNAMICS OF SOMATIC EVOLUTION IN APLASTIC ANEMIA AND PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

EHA Library, Kudzai Nyamondo, 4206729

DISTINCT IMMUNE DIVERSITY OF CD8+ T CELLS DEFINES PEDIATRIC HEPATITIS-ASSOCIATED APLASTIC ANEMIA AND SEVERE APLASTIC ANEMIA

EHA Library, Lixian Chang, 4206731

EARLY BONE FRAGILITY IS ASSOCIATED WITH VASCULAR ABNORMALITIES IN TELOMERE BIOLOGY DISORDERS: FINDINGS FROM THE MULTICENTER, INTERNATIONAL INSIGHT STUDY

EHA Library, Jane Koo, 4206733

SUCCESSFUL IN VIVO CAR-T GENERATION AND MINIMAL RESIDUAL DISEASE (MRD) CLEARANCE WITH KLN-1010 ACROSS DIVERSE BASELINE T CELL PHENOTYPES IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)

EHA Library, Andrew Spencer, 4206739

NIPOCALIMAB FOR WARM AUTOIMMUNE HEMOLYTIC ANEMIA: RESULTS FROM THE PHASE 2/3 RANDOMIZED DOUBLE-BLIND ENERGY STUDY

EHA Library, Bruno Fattizzo, 4206854

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY OF ESLIM-02 FOR EFFICACY AND SAFETY OF SOVLEPLENIB (HMPL-523) IN PATIENTS WITH WARM AUTOIMMUNE HEMOLYTIC ANEMIA IN CHINA

EHA Library, Bing Han, 4206855

VENGLUSTAT DEMONSTRATES SUPERIOR NEUROLOGIC EFFICACY WHILE MAINTAINING SYSTEMIC CONTROL IN GAUCHER DISEASE TYPE 3: RESULTS FROM THE PHASE 3 LEAP2MONO TRIAL

EHA Library, Irene Motta, 4206857

EFFECTS OF MITAPIVAT ON IRON BURDEN AND SPLEEN SIZE IN ERYTHROCYTE MEMBRANOPATHIES AND CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE II: 56-WEEK FOLLOW-UP RESULTS FROM THE SATISFY STUDY

EHA Library, Thomas Doeven, 4206858

OUTPATIENT TREATMENT WITH GLOFITAMAB PLUS GEMCITABINE AND OXALIPLATIN (GEMOX) IN RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): PRELIMINARY SAFETY RESULTS FROM A PHASE 2 STUDY

EHA Library, Dok Hyun Yoon, 4206889

REAL-WORLD EFFICACY AND SAFETY OF THE MEDZ-R REGIMEN AS INDUCTION THERAPY IN NEWLY DIAGNOSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA

EHA Library, Liqun Zou, 4206890

THE PREDIC-TO STUDY: AN INTERNATIONAL, REAL-WORLD COHORT STUDY OF VENOUS THROMBOEMBOLISM RISK MODEL STRATIFICATION IN DLBCL PATIENTS ACROSS ASIA, EUROPE, AND UNITED STATES OF AMERICA

EHA Library, Giulia Bassi, 4206891

TEMPORAL TRENDS IN HEPATITIS B RISK FOLLOWING LYMPHOMA: A POPULATION-BASED ANALYSIS USING SWEDISH LYMPHOMA REGISTRY DATA (2002–2024)

EHA Library, Torsten Dahlén, 4206892

REAL-WORLD ASIAN MULTI-CENTRE COHORT STUDY ON OUTCOMES OF POLA-R-CHP IN UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Nicole-Ann Lim, 4206893

ADDITION OF HIGH-DOSE METHOTREXATE TO STANDARD FIRST-LINE IMMUNOCHEMOTHERAPY IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA IS ASSOCIATED WITH ACUTE BUT NOT CHRONIC KIDNEY DISEASE

EHA Library, Silje Post Strøm, 4206897

NOVA-BCL6-1: A FIRST-IN-HUMAN PHASE 1 TRIAL OF LY4584180, A NOVEL BCL6 MOLECULAR GLUE, IN PATIENTS WITH RELAPSED/REFRACTORY B-CELL MALIGNANCIES (TRIAL IN PROGRESS)

EHA Library, Yair Levy, 4206898

DEVELOPMENT OF A PROGNOSTIC MODEL INCORPORATING PLASMA EBV-DNA LEVEL FOR EBV-POSITIVE DIFFUSE LARGE B-CELL LYMPHOMA: A RETROSPECTIVE, SINGLE-CENTER STUDY

EHA Library, Xinzhu Tang, 4206902

MULTIVARIABLE ANALYSES OF OVERALL SURVIVAL IN THE PHASE 3 SUNMO, STARGLO AND POLARGO TRIALS IN RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA

EHA Library, Matthew Matasar, 4206907

OUTCOMES OF CONSOLIDATIVE RADIOTHERAPY AND SURVIVAL IN LIMITED-STAGE PRIMARY GASTRIC DIFFUSE LARGE B-CELL LYMPHOMA ACHIEVING COMPLETE RESPONSE: A MULTICENTER STUDY FROM CHINA

EHA Library, Natalia Sunarto, 4206910

POLA-RCHP FOR DLBCL PATIENTS WITH EXTRANODAL INVOLVEMENT: REAL-WORLD EVIDENCE IN AN UNDERREPRESENTED POPULATION

EHA Library, Xi Chen, 4206911

METAGENOMIC STUDY ON THE DYNAMIC CHANGES OF GUT MICROBIOME-METABOLOME IN DIFFUSE LARGE B-CELL LYMPHOMA: A COHORT ANALYSIS BASED ON PATIENTS' HEALTHY COHABITANTS AS CONTROL

EHA Library, Sai Huang, 4206914

ZANUBRUTINIB PLUS R-CHOP (ZR-CHOP) IN NON-GERMINAL CENTER B-CELL-LIKE (NON-GCB) DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS WHO WERE POSITRON EMISSION TOMOGRAPHY-POSITIVE AFTER TWO CYCLES OF R-CHOP

EHA Library, Jie Wang, 4206916

EFFICACY OF CAR-T CELL THERAPY IN DOUBLE-EXPRESSOR TP53-POSITIVE RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: A MULTICENTER REAL-WORLD STUDY

EHA Library, Shihui Ren, 4206917

UPDATED CLINICAL DATA FROM THE PHASE 1/2 STUDY OF DIBOTATUG (DR-01), A NON-FUCOSYLATED ANTI-CD94 ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY CYTOTOXIC T/NK CELL LYMPHOMAS

EHA Library, Swaminathan Iyer, 4206919

SINGLE-CELL ANALYSES IDENTIFY A DISTINCT MYELOID CELL ECOSYSTEM ASSOCIATED WITH TREATMENT RESISTANCE IN ANAPLASTIC LARGE CELL LYMPHOMA

EHA Library, Putri Ramadani, 4206921

REAL-WORLD MANAGEMENT AND OUTCOMES OF PTS WITH PRIMARY MEDIASTINAL B-CELL LYMPHOMA: INSIGHTS FROM THE FRENCH REALYSA COHORT.

EHA Library, Loic Renaud, 4206923

BLOOD CANCER ASSOCIATED HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IS MORE LIKELY IN YOUNGER PATIENTS, AND ONLY AGE AND T-, NKT- AND NK-CELL LYMPHOMA DIAGNOSIS IMPACT SURVIVAL.

EHA Library, Mark Bishton, 4206927

COMPARABLE EFFICACY AND SAFETY OF BRENTUXIMAB VEDOTIN -BASED THERAPY TO THE ECHELON TRIALS: REAL-WORLD EVIDENCE FROM THE BRAVE STUDY

EHA Library, Mingci Cai, 4206928

MITOXANTRONE HYDROCHLORIDE LIPOSOME-BASED CMOP±R REGIMEN FOR PREVIOUSLY UNTREATED NON-HODGKIN LYMPHOMA: RESULTS FROM A PHASE 3 MULTICENTER STUDY

EHA Library, Haiwen Huang, 4206931

REAL-WORLD CHARACTERISTICS AND SURVIVAL OUTCOMES OF AGGRESSIVE NATURAL KILLER CELL LEUKEMIA IN THE UNITED STATES

EHA Library, Cher Ying Foo, 4206935

AMPLIFICATION OF STAT3 AND TP53 MAY CONFER POOR PROGNOSIS IN PERIPHERAL T-CELL LYMPHOMA: ANALYSIS OF A SINGLE-CENTER COHORT

EHA Library, Alessandro Putelli, 4206937

PROPOSED DEFINITION FOR ‘PRIMARY REFRACTORY’ DISEASE IN NODAL PERIPHERAL T-CELL LYMPHOMA: AN AUSTRALASIAN-CANADIAN COLLABORATIVE STUDY

EHA Library, John Kuruvilla, 4206939

RARE GERMLINE VARIANTS SHAPE SUSCEPTIBILITY AND PROGNOSIS IN B-CELL LYMPHOMAS

EHA Library, Weicheng Ren, 4206941

EFFICACY AND SAFETY OF GOLIDOCITINIB-CONTAINING REGIMENS IN RELAPSED/REFRACTORY PERIPHERAL T CELL LYMPHOMA: A REAL WORLD STUDY

EHA Library, Liufang Gu, 4206942

REAL-WORLD OUTCOMES OF PERIPHERAL AND CUTANEOUS T-CELL LYMPHOMAS IN KAZAKHSTAN: A NATIONWIDE MULTICENTER STUDY

EHA Library, Ayazhan Umutbayeva, 4206943

TARGETING TNFR2 WITH BI-1808 WITH OR WITHOUT PEMBROLIZUMAB: IMMUNE ACTIVATION AND PROMISING RESPONSES IN ADVANCED CUTANEOUS T-CELL LYMPHOMAS

EHA Library, Stefan Barta, 4206947

SPATIAL TRANSCRIPTOMICS REVEALS STEPWISE FORMATION OF DISTINCT CUTANEOUS NICHES IN NODAL T FOLLICULAR HELPER CELL LYMPHOMA

EHA Library, Yuri Tsuboi, 4206951

PERIPHERAL PROTEOMIC SIGNATURES ASSOCIATED WITH CYTOKINE RELEASE SYNDROME (CRS) IN PATIENTS (PTS) WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) AND FOLLICULAR LYMPHOMA (FL) TREATED WITH ODRONEXTAMAB

EHA Library, Stefano Luminari, 4206977